Medtronic Launches Laser Ablation System in European Market
Medtronic PLC announced the CE (Conformité Européenne) mark and European launch of the Visualase MRI-guided laser ablation system. The Visualase system provides advanced MRI-guided laser ablation technology and can be used in neurosurgery procedures.
With the Visualase system, laser energy is delivered to the target area using an applicator. As light is delivered through the applicator, temperatures in the target area begin to rise, destroying the unwanted soft tissue
The Visualase procedures are guided by MRI images and provide precise and controlled ablation. Because of the minimally invasive nature of the procedure, patients typically go home the next day.
The Visualase system received FDA clearance in the U.S. in July 2007 to necrotize or coagulate soft tissue. Medtronic is currently involved in a pivotal SLATE (stereotactic laser ablation for temporal lobe epilepsy) study in the U.S. to support an expanded FDA indication for the treatment of epilepsy in patients with drug-resistant mesial temporal lobe epilepsy, the most common form of partial or localization related epilepsy.
Medtronic is a developer of medical technology, services, and solutions for the health industry.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024